期刊文献+

抑癌基因与原癌基因在正常细胞与癌细胞中的表达水平与甲基化比较

Expression of Tumor Suppressor Genes and Oncogenes and DNA Methylation in Normal Cells and Cancer Cells
下载PDF
导出
摘要 选取抑癌基因和癌基因转录起始位点和转录终止位点上下2000bp,研究它们在癌细胞和正常细胞中甲基化分布差别,结果表明抑癌基因在癌细胞比正常细胞甲基化分布高,并且抑癌基因甲基化分布集中于转录起始位点前后1000bp,而原癌基因的甲基化分布要比抑癌基因的分布广.然后又对每个抑癌基因和原癌基因转录起始位点和转录终止位点的甲基化水平进行了研究,找出了在所选的癌细胞比正常细胞甲基化高的抑癌基因RUNX3,WT1,发现它们都是转录因子且生物学功能相似. The difference of methylation between the tumor suppressor genes and the oncogenes flanking transcription start site (TSS) and transcription termination site (TTS) around 2000bp in cancer cells and normal cells is calculated. The results show that the distribution of methylation of tumor suppressor genes in cancer cells is higher than in normal cells, these genes mainly locate in 1000bp region flanking transcription start site, and the distribution of methylation of oncogenes has wider region than tumor suppressor genes. By studying the value of methylation for every gene flan- king the transcription start site and transcription termination site, there are two tumor suppressor genes,RUNX3 and WT1 which have the biggest difference of methylation in cancer cells and normal cells,and both of them are transcription factors and the thebiological function is similar.
作者 杨敏 李前忠
出处 《内蒙古大学学报(自然科学版)》 CAS 北大核心 2015年第6期630-636,共7页 Journal of Inner Mongolia University:Natural Science Edition
基金 国家自然科学基金资助项目(No.31460234)
关键词 DNA甲基化 抑癌基因 原癌基因 DNA methylation tumor suppressor genes oncogenes
  • 相关文献

参考文献19

  • 1Kulis M, Esteller M. DNA Methylation and Cancer [ C]//Advances in Genetics. Amsterdam;Elseeier academic press ine,2010:70 : 27-56.
  • 2Mulero-Navarro S, Esteller M. Epigenetic biomarkers for human cancel. The time is now[J], critical reciews in oncology hematology, 2008,68 ( 1 ) : 1-11.
  • 3Aisner D L,Marshall C B. Molecular Pathology of Non-Small Cell Lung Cancer A Practical Guide[J]. american journal of clinical pathology ,2012,138(3) :332-346.
  • 4Youssef E M, Lotan D, Issa J P, et al. H ypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis[J], clinical cancer research ,2004,10(5) : 1733-1742.
  • 5Zhao R,Casson A G. Epigenetic Aberrations and Targeted Epigenetic Therapy oi" Esophageal Cancer[J]. current cancer drug targets, 2008,8(6) : 509-521.
  • 6Agathanggelou A,Cooper W N, Latif F. Role of the ras-association domain family 1 tumor suppressor gene in hu- man cancers[J], cancer research ,2005,65(9) :3497-3508.
  • 7王智超,原涛.癌基因、原癌基因与抑癌基因[J].中学生物学,2004,20(6):2-3. 被引量:3
  • 8Dedeurwaerder S,Defrance M,Calonne E, et al. Evaluation of the Infinium Methylation 450K technologyrJ], epl- genomics, 2011,3(6) : 771-784.
  • 9Rebhan M,Chalifa-Caspi V, Prilusky J, et al. GeneCards: integrating information about genes, proteins and disea- ses[J]. Trends in Genetics, 1997,13 (4) : 163.
  • 10Rebhan M, Chalifa-Caspi V, Prilusky J, et al. GeneCards: integrating information about genes, proteins and disea- ses[J]. Trends in Genetics : T IG , 1997,13(4) : 163.

二级参考文献11

  • 1[1]Khoury G, Gruss P. Cell, 1983; 33(2): 313-314.
  • 2[2]Liu Q H, Bungert J, Engel J D. Proc Natl Acad Sci USA, 1997; 94: 169-174.
  • 3[3]Udvardy A. EMBO J, 1999; 18: 1-8.
  • 4[4]Walters M C, Fiering S, Eidemiller J, et al. Proc Natl Acad Sci USA, 1995; 92: 7125-7129.
  • 5[5]Forsberg E C, Zaboikina T N, Versaw W K, et al. Mol Cell Biol, 1999; 19: 5565-5575.
  • 6[6]Weintraub H. Proc Natl Acad Sci USA, 1988; 85:5819-5823.
  • 7[7]Sutherland H G E, Martin D I K, Whitelaw E. Mol Cell Biol, 1997; 17: 1607-1614.
  • 8[8]Viswanath R L, Rose S D, Swift G H, et al. J Biol Chem, 2000; 275: 40273-40281.
  • 9[9]Graubert T A, Hug B A, Wesselschmidt R, et al. Nucleic Acids Res, 1998; 26(12): 2849-2858.
  • 10[10]Guy L G, Kothary R, Wall L. Nucleic Acids Res, 1997;25: 4400-4408.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部